Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
Nevada Governor Joe Lombardo Named BIO’s Governor…
WASHINGTON, DC (August 31, 2026) – Today, the Biotechnology Innovation Organization (BIO) awarded Nevada Governor Joe Lombardo with its 2026 Governor of the Year Award, recognizing his leadership in growing the life sciences in Nevada and commitment…
Learn more
BIO Supports PDUFA VIII Commitment Letter and…
Biotechnology Innovation Organization (BIO) Senior Vice President of Science & Regulatory Affairs Annetta Beauregard issued the following statement on the release of the Prescription Drug User Fee Act (PDUFA) VIII commitment letter:“For more…
Learn more
BIO Statement on Senate Reintroduction of the…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the reintroduction of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance …
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
National Bioscience Industry Report Shows $2T Economic Impact, Accelerated Venture Capital Investment & Job Growth
June 5, 2018
A study released today at the BIO International Convention shows that the U.S. bioscience industry has reached $2 trillion in annual economic impact while maintaining accelerated venture capital investment and job growth numbers. Among U.S…
New Bioscience Report Shows Record-Breaking Economic Impact, Accelerated Venture Capital Investment & Job Growth
June 4, 2018
BIO’s latest report shows that the U.S. bioscience industry has reached record setting annual economic impact, venture capital investment and job growth numbers. Among U.S. technology sectors, the bioscience industry is a leading economic driver and…
New Report Shows Substantial Economic Costs of Chinese Delays on Ag-Biotech Approvals
May 30, 2018
Washington, D.C. (May 30, 2018) – Persistent delays in China’s ag-biotech regulatory system slows U.S. farmers’ access to new biotechnology products and costs the U.S. economy tens of thousands of jobs and billions in economic output, according to a…
BIO Announces Renewable Chemicals Programming for 2018 World Congress
May 25, 2018
The Biotechnology Innovation Organization (BIO) today announced programming information for renewable chemicals at the 2018 BIO World Congress on Industrial Biotechnology. Programming will consist of four breakout sessions on Tuesday, July 17,…
Biotech Leader Testifies Before House Capital Markets Subcommittee
May 23, 2018
Washington, DC (May 23, 2018) – Brian Hahn, Chief Financial Officer of GlycoMimetics, Inc., provided testimony today on behalf of the Biotechnology Innovation Organization (BIO) before the House of Representatives Committee on Financial…
Biotech in Our Backyard Panel to Highlight Agricultural Innovation in New England Region
May 23, 2018
Washington, D.C. (May 23, 2018) - Even with the abundance of high-profile international companies that will converge in Boston for the 2018 BIO International Convention, it’s difficult to overstate the work that is being done in Boston’s backyard…
BIO 2018 to Feature Rob Reiner as Keynote Speaker
May 21, 2018
Aactor, director and advocate Rob Reiner will deliver a keynote address at the 2018 BIO International Convention, the world’s premier life sciences event being held in Boston, June 4-7. Reiner’s family story of drug addiction reinforces the urgent…
Food Evolution Writer/Producer Trace Sheehan to Keynote Food & Ag Program at BIO Int’l Convention
May 16, 2018
Washington, D.C. (May 16, 2018) – Trace Sheehan, writer and producer of the highly-acclaimed documentary film Food Evolution, will be a keynote speaker at BIO’s International Convention in Boston, the Biotechnology Innovation Organization (BIO)…
BIO Statement on Trump Administration’s Plan to Lower Drug Costs
May 11, 2018
“We have concerns that some of the ideas proposed today could, if adopted, hurt patient access to the medicines they need …”
BIO’s Statement on PTO’s Proposed Changes to the Claim Construction Standard for PTAB Proceedings
May 9, 2018
Washington, D.C. (May 9, 2018) – Biotechnology Innovation Organization President for Advocacy, Law & Public Policy Tom DiLenge today issued the following statement in response to the U.S. Patent and Trademark Office’s (PTO) proposed change to…